Robert Lisicki is a director of Cadrenal Therapeutics, Inc. Common Stock.
Person profile
Roles
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Zura Bio Ltd
21 Jun 24
4
Zura Bio Ltd
26 Jan 24
4
Cadrenal Therapeutics, Inc.
19 Jan 24
3
Zura Bio Ltd
8 Jan 24
4
Cadrenal Therapeutics, Inc.
24 Jul 23
3
Cadrenal Therapeutics, Inc.
24 Jul 23
4
ARENA PHARMACEUTICALS INC
11 Mar 22
4
ARENA PHARMACEUTICALS INC
5 Jan 22
4
ARENA PHARMACEUTICALS INC
5 Aug 21
4
ARENA PHARMACEUTICALS INC
3 Mar 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Jun 24 | ZURA Zura Bio Limited | Employee Share Option Class A Ordinary Shares | Grant | Acquire A | No | No | 3.38 | 1,050,000 | 3.55 mm | 1,050,000 |
24 Jan 24 | ZURA Zura Bio Limited | Stock options Class A Ordinary Shares | Grant | Acquire A | No | No | 3.98 | 1,000,000 | 3.98 mm | 1,000,000 |
18 Jan 24 | CVKD Cadrenal Therapeutics, Inc. Common Stock | Stock Options Common Stock | Grant | Acquire A | No | No | 0.94 | 50,000 | 47.00 k | 50,000 |